Form 4: Regina Groves Acquires AtriCure Stock

Regina E. Groves, a Director at AtriCure, Inc., acquired 6,144 shares of common stock through a Restricted Stock Award.

Summary

• Regina E. Groves, a Director at AtriCure, Inc., acquired 6,144 shares of common stock on May 18, 2026.
• The acquisition was made through a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan.
• These shares are subject to vesting upon the one-year anniversary of the grant date.
• Following this transaction, Ms. Groves beneficially owns 39,859 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard stock award to a director rather than an open market purchase or sale.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition is part of a formal stock incentive plan, suggesting a structured approach to executive compensation and alignment with shareholder interests.

Future Outlook

The shares acquired are subject to vesting upon the one-year anniversary of the grant date, indicating a future milestone for these shares to become fully owned by the reporting person.

Industry Context

StockSavvy.ai notes that insider stock awards are common in the medical device industry as a tool for executive compensation and retention, aligning management's interests with long-term company performance.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of commitment, but it does not represent new capital for the company.

Next Steps

• The acquired shares will vest upon the one-year anniversary of the grant date.

Key Dates

Keywords

AtriCure, ATRC, Form 4, Insider Trading, Restricted Stock Award, Director, Securities Ownership